Indicators

Markets:

News

Latest News about Fold

Recent news which mentions Fold

< Previous 1 2 Next >

Recap: Amicus Therapeutics Q3 Earnings

November 07, 2022

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

November 01, 2022

FDA Defers Action On Amicus Therapeutics' Much Awaited Pompe Disease Therapy

October 31, 2022

AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know

October 02, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022

September 09, 2022

Billionaire Joe Edelman’s biotech hedge fund hit with SEC charges for not disclosing SPAC conflicts

September 06, 2022

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know

August 31, 2022

iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday

August 08, 2022

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday

August 08, 2022

This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket

August 03, 2022

PayPal, SoFi Technologies And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

August 03, 2022

Biotech Investors: August's Key PDUFA Catalysts You Must Know

July 31, 2022

Short Volatility Alert: Amicus Therapeutics, Inc.

June 22, 2022

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

May 31, 2022

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine

May 11, 2022

7 Biotech Stocks With Key Catalysts for May

May 11, 2022

FDA Extends Review Of Amicus Therapeutics' AT-GAA For The Treatment Of Pompe Disease By Three Months

May 10, 2022

Recap: Amicus Therapeutics Q1 Earnings

May 09, 2022

Earnings Outlook For Amicus Therapeutics

May 06, 2022

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates

May 01, 2022

Amicus Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know

April 27, 2022

Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease

March 16, 2022

Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall

February 24, 2022

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

February 24, 2022

Amicus Therapeutics Earnings Preview

February 23, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022

January 14, 2022

10 Biggest Price Target Changes For Friday

January 14, 2022

60 Biggest Movers From Yesterday

January 11, 2022

Mid-Afternoon Market Update: Dow Tumbles 250 Points; Zynga Shares Spike Higher

January 10, 2022

Mid-Day Market Update: Nasdaq Dips 300 Points; Apria Shares Surge

January 10, 2022

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.